Finance

Lists
Why is OMDA down २.५२%?
Dive Deeper
OMDA:NASDAQ
Omada Health Inc
US$ १४.३३
-२.५२%
(-०.३७) 1D
नोभेम्बर १३, १६:००:०० GMT-५  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OMDA...
Open
US$ १४.८२
High
US$ १४.८८
Low
US$ १४.१८
Mkt. cap
८८.९० करोड
Avg. vol.
१२.४९ लाख
Volume
१२.०५ लाख
P/E ratio
२१७.८८
52-wk high
US$ २५.४४
52-wk low
US$ १०.२८
EPS
US$ ०.०७
Shares outstanding
६.२० करोड
No. of employees
९८०
Open
US$ १४.८२
High
US$ १४.८८
Low
US$ १४.१८
Mkt. cap
८८.९० करोड
Avg. vol.
१२.४९ लाख
Volume
१२.०५ लाख
P/E ratio
२१७.८८
52-wk high
US$ २५.४४
52-wk low
US$ १०.२८
EPS
US$ ०.०७
Shares outstanding
६.२० करोड
No. of employees
९८०
News stories
From web sources and news partners
About Omada Health Inc
CEO-
Employees९८०
Founded२०११
HeadquartersSouth San Francisco, क्यालिफोर्निया, संयुक्त राज्य अमेरिका
SectorHealth Care
Industry-
Analyst ratings
Based on 9 analysts giving stock ratings to OMDA in the past 3 months
Strong buy
Buy
8
Hold
1
Sell
0
12-month forecast
Based on 9 Wall Street analysts offering 12 month price targets for OMDA in the last 3 months.
Highest
Current US$ १४.३३
US$ ३५.०० (+१४४.२४%)
Average
US$ २७.३३ (+९०.७२%)
Lowest
US$ १९.०० (+३२.५९%)
Analyst
Recommendation
Action
Price target
Projected
Date
Craig Hettenbach
Morgan Stanley
Buy
Reiterated
US$ ३०.००
+१०९.४%
11/09/2026
Richard Close
Canaccord Genuity
Buy
Reiterated
US$ २८.००
+९५.४%
11/06/2026
Sean Dodge
BMO Capital
Buy
Maintained
US$ २४.००
+६७.५%
11/05/2026
Stan Berenshteyn
Wells Fargo
Hold
Maintained
US$ १९.००
+३२.६%
11/05/2026
David Larsen
BTIG
Buy
Reiterated
US$ ३५.००
+१४४.२%
11/05/2026
Saket Kalia
Barclays
Buy
Maintained
US$ २२.००
+५३.५%
11/06/2026
Eugene Mannheimer
Freedom Capital Markets
Buy
Reiterated
US$ ३५.००
+१४४.२%
09/14/2026
Elizabeth Anderson CFA
Evercore ISI
Buy
Maintained
US$ २५.००
+७४.५%
09/11/2026
Ryan MacDonald
Needham
Buy
Reiterated
US$ २८.००
+९५.४%
09/11/2026
Lisa Gill
J.P. Morgan
Buy
Maintained
US$ ३०.००
+१०९.४%
08/14/2026
Constantine Davides
Citizens JMP
Buy
Maintained
US$ २७.००
+८८.४%
07/20/2026
David Roman
Goldman Sachs
Buy
Maintained
US$ २५.००
+७४.५%
06/10/2026
Last report
२०२६ नोभेम्बर ५
Fiscal period
Q3 2026
US$ ०.२१ / US$ ०.१०
+११४.२७%beat
Revenue / Est. (USD)
९.१३ करोड / ८.५६ करोड
+६.६२%beat
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
२०२६ सेप्टेम्बर
Revenue
७.५८ करोड
७.८० करोड
८.७८ करोड
९.१३ करोड
Cost of goods sold
२.२२ करोड
२.९४ करोड
२.४० करोड
२.२० करोड
Cost of revenue
२.२२ करोड
२.९४ करोड
२.४० करोड
२.२० करोड
Research and development expenses
१.१६ करोड
१.२७ करोड
१.४६ करोड
१.५३ करोड
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
३.८८ करोड
४.०८ करोड
४.५६ करोड
४.९२ करोड
Operating expense
५.०४ करोड
५.३५ करोड
६.०२ करोड
६.४५ करोड
Total operating expenses
७.२६ करोड
८.२८ करोड
८.४३ करोड
८.६५ करोड
Operating income
३२.८१ लाख
-४७.८१ लाख
३५.४९ लाख
४८.२० लाख
Other non operating income
-
-
-
-
EBT including unusual items
५१.५९ लाख
-२९.७० लाख
५२.९४ लाख
६५.५१ लाख
EBT excluding unusual items
५१.५९ लाख
-२९.७० लाख
५२.९४ लाख
६५.५१ लाख
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
५१.५९ लाख
-२९.७० लाख
५२.९४ लाख
६५.५१ लाख
Net profit margin
६.८०%
-३.८१%
६.०३%
७.१७%
Earnings per share
०.१६
०.०५
०.२०
०.२१
Interest and investment income
१८.९१ लाख
१८.२९ लाख
१७.५९ लाख
१९.९३ लाख
Interest expense
-१३.०० हजार
-१८.०० हजार
-१४.०० हजार
-२.६२ लाख
Net interest expenses
१८.७८ लाख
१८.११ लाख
१७.४५ लाख
१७.३१ लाख
Depreciation and amortization charges
-
-
-
-
EBITDA
४७.२८ लाख
-३२.७३ लाख
५१.३० लाख
६५.०१ लाख
Gain or loss from assets sale
६.०० हजार
२.०० हजार
२५.०० हजार
२७.०० हजार
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
Google एपहरू